KH
Knight Therapeutics Inc.
KHTRF · OTC
$7.24 +1.26% (+$0.09)
1M +2.14%
Market Cap $982.2M
P/E Ratio 66.87x
Div. Yield -
ROE 1.88%
Bulios Fair Price
$3.79
47.7% downside
Trenutna cena
$7.24
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KHTRF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
67 /100
Cheap P/E 66.87x
P/FCF 8.92x
EV/EBITDA 11.34x
Growth
82 /100
Growing Rev. growth 15.28%
Book val. growth 2.45%
FCF growth 67.03%
Profitability
56 /100
Moderate Gross margin 39.34%
FCF margin 20.09%
Net margin 2.68%
Quality
14 /100
Poor ROIC 2.09%
Asset turnover 0.52x
ROE 1.88%
Debt
84 /100
Low Debt/Equity 0.04x
Net debt/EBITDA -0.73x
Current ratio 2.28x
Stability
31 /100
Unstable Beta 0.05x
Profitable years 0
Rev. volatility 5.04%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KHTRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Samira Sakhia
Employees
830
Headquarters
Montreal
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report